| Name | Title | Contact Details |
|---|---|---|
Shane Arledge |
vice president of financial planning and analysis | Profile |
Avaxia is a leader in the growing field of gut-targeted therapeutics — orally administered, minimally absorbed drugs that are designed to act locally in the gastrointestinal tract. Avaxia’s lead clinical candidate, AVX-470, is an oral anti-TNF antibody for inflammatory bowel disease. This transformative product offers potentially improved safety and efficacy over existing anti-TNF therapies by focusing immune suppression only where needed in the diseased gut. Avaxia plans to use its gut-targeted antibody platform to develop therapeutics to address many other serious diseases such as type 2 diabetes, celiac disease, GI acute radiation syndrome and oral mucositis.
Lifestar Ambulance is a Centralia, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
cambridge healthcare is a Chantilly, VA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
eDerm Systems is a Boca Raton, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
FitRankings is a universal platform for fitness. FitRankings converts all activity from any wearable or fitness app into one measurement unit that is recognized by the CDC (MET Minute). FitRankings is currently focused on re-defining the $10B Corporate Wellness using real-time data from the latest wearable tech and fitness apps. FitRankings Enterprise Solution is used by leading workplaces, Fortune 1000 companies, and government agencies to lower healthcare costs, and keep employees healthy and engaged.